Functional antibody CDR3 fusion proteins with enhanced pharmacological properties

Angewandte Chemie - International Edition

Volumn 52, Issue 32, 2013, Pages 8295-8298

  Zhang, Yong ^a,b   Wang, Danling ^a,b   De Lichtervelde, Lorenzo ^a   Sun, Sophie B ^a   Smider, Vaughn V ^a   Schultz, Peter G ^a,b   Wang, Feng ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b California Institute for Biomedical Research   (United States)

Author keywords

antibodies; pharmacology; polypeptide; protein engineering; ultralong CDR

Indexed keywords

FUSION PROTEINS; NOVEL STRATEGIES; PHARMACOKINETICS AND PHARMACODYNAMICS; PHARMACOLOGICAL PROPERTIES; PHARMACOLOGY; PROTEIN ENGINEERING; ULTRALONG CDR;

CHEMICAL REACTIONS; CHEMISTRY; POLYPEPTIDES;

ANTIBODIES;

ANTIBODY; POLYPEPTIDE;

ANIMAL; ARTICLE; CATTLE; COMPLEMENTARITY DETERMINING REGION; METABOLISM; METHODOLOGY; MOUSE; PHARMACOLOGY; PROTEIN ENGINEERING; ULTRALONG CDR;

ANTIBODIES; PHARMACOLOGY; POLYPEPTIDE; PROTEIN ENGINEERING; ULTRALONG CDR;

ANIMALS; CATTLE; COMPLEMENTARITY DETERMINING REGIONS; MICE; PROTEIN ENGINEERING;

EID: 84882255351     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201303656     Document Type: Article

References (19)

1. E. O. Saphire, P. W. Parren, R. Pantophlet, M. B. Zwick, G. M. Morris, P. M. Rudd, R. A. Dwek, R. L. Stanfield, D. R. Burton, I. A. Wilson, Science 2001, 293, 1155-1159
2. R. Pejchal, L. M. Walker, R. L. Stanfield, S. K. Phogat, W. C. Koff, P. Poignard, D. R. Burton, I. A. Wilson, Proc. Natl. Acad. Sci. USA 2010, 107, 11483-11488.
3. S. J. Berens, D. E. Wylie, O. J. Lopez, Int. Immunol. 1997, 9, 189-199
4. O. Lopez, C. Perez, D. Wylie, Immunol. Rev. 1998, 162, 55-66
5. S. S. Saini, B. Allore, R. M. Jacobs, A. Kaushik, Eur. J. Immunol. 1999, 29, 2420-2426
6. S. S. Saini, W. Farrugia, P. A. Ramsland, A. K. Kaushik, Int. Immunol. 2003, 15, 845-853
7. Y. Zhao, S. M. Jackson, R. Aitken, Dev. Comp. Immunol. 2006, 30, 175-186.
8. F. Wang, D. C. Ekiert, I. Ahmad, W. Li, Y. Zhang, O. Bazirgan, A. Torkamani, T. Raudsepp, W. Mwangi, M. F. Criscitiello, I. A. Wilson, P. G. Schultz, V. V. Smider, Cell 2013, 153, 1379-1393.
9. E. D. Lobo, R. J. Hansen, J. P. Balthasar, J. Pharm. Sci. 2004, 93, 2645-2668
10. D. Ternant, G. Paintaud, Expert Opin. Biol. Ther. 2005, 5 Suppl. 1, S37- 47.
11. B. Lovejoy, D. Cascio, D. Eisenberg, J. Mol. Biol. 1993, 234, 640-653.
12. K. L. Cooper, J. Madan, S. Whyte, M. D. Stevenson, R. L. Akehurst, BMC Cancer 2011, 11, 404.
13. G. Morstyn, L. Campbell, L. M. Souza, N. K. Alton, J. Keech, M. Green, W. Sheridan, D. Metcalf, R. Fox, Lancet 1988, 331, 667-672.
14. G. N. Cox, D. J. Smith, S. J. Carlson, A. M. Bendele, E. A. Chlipala, D. H. Doherty, Exp. Hematol. 2004, 32, 441-449
15. G. de Haan, A. Ausema, M. Wilkens, G. Molineux, B. Dontje, Br. J. Haematol. 2000, 110, 638-646.
16. D. C. Roopenian, S. Akilesh, Nat. Rev. Immunol. 2007, 7, 715-725.
17. Y. Bai, D. K. Ann, W. C. Shen, Proc. Natl. Acad. Sci. USA 2005, 102, 7292-7296
18. N. Shirafuji, S. Asano, S. Matsuda, K. Watari, F. Takaku, S. Nagata, Exp. Hematol. 1989, 17, 116-119.
19. L. de Lichtervelde, C. E. Antal, A. E. Boitano, Y. Wang, P. Krastel, F. Petersen, A. C. Newton, M. P. Cooke, P. G. Schultz, Chem. Biol. 2012, 19, 994-1000.